A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Clinical trial NCT07564414 · RECRUITING
Trial details
- NCT number
- NCT07564414
- Sponsor
- Novo Nordisk A/S
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-21
- Primary completion
- 2028-02-23
- Enrollment
- 2500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.